Ablaze Pharmaceuticals

📍 Shanghai, China🗓 Founded 2021👥 10 employees💰 Last funded Nov 2021
Pharmaceutical Manufacturing🌐 ablazepharma.com
Website LinkedIn
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company with a mission to bring advanced targeted radiopharmaceutical therapies (TRT) to benefit cancer patients in China. Since its inception, Ablaze has secured a partnership with RayzeBio, Inc., an innovative radiopharmaceutical company based in San Diego CA, to gain exclusive development and commercial right to a series of RayzeBio’s products in the greater China region. Leveraging its team’s extensive business experience and network in cross-border product development and deal making, Ablaze strives to become the leader and the partner of choice in the emerging TRT market in China by working with strategic business partners in both China and abroad. For more information, please visit www.ablazepharma.com.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Hong Kong SAR
1
Frequently asked questions
Who invested in Ablaze Pharmaceuticals?
Ablaze Pharmaceuticals has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Ablaze Pharmaceuticals last raise funding?
The most recent investment in Ablaze Pharmaceuticals recorded on gritt.io was in November 2021.
When was Ablaze Pharmaceuticals founded?
Ablaze Pharmaceuticals was founded in 2021.
What industry is Ablaze Pharmaceuticals in?
Ablaze Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Ablaze Pharmaceuticals based?
Ablaze Pharmaceuticals is headquartered in Shanghai, China.